PerkinElmer Launches Explorer Series Workstations for High-Throughput SARS-CoV-2 Testing With 10,000 COVID-19 Tests Capacity per Day
By LabMedica International staff writers
Posted on 19 Aug 2020
PerkinElmer, Inc. (Waltham, MA; USA) has launched a series of explorer workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day. Posted on 19 Aug 2020
These modular and scalable workstations will enable laboratories to ramp up SARS-CoV-2 testing capacity quickly to generate results. Currently, several laboratories are unable to deliver COVID-19 testing results in a timely manner. PerkinElmer’s scalable and modular explorer automated workstations streamline testing workflows, speeding up SARS-CoV-2 RT-PCR and ELISA testing. The workstations help laboratories improve their efficiency, while eliminating errors. In addition, they reduce labor requirements by automating and standardizing disparate workflow steps. They also provide varying degrees of automation based on workload and staffing resources.
To better respond to the COVID-19 pandemic, laboratories need the ability to obtain all workflow components – from reagents to equipment, to consumables at the scale they need, when they need them. PerkinElmer is currently able to deliver these workflow components globally.
“The global economy is reeling from this pandemic, and laboratories need to be able to rapidly scale their testing capacity up and down,” said Masoud Toloue, Ph.D., Vice President and General Manager, Diagnostics, PerkinElmer. “PerkinElmer is developing innovative solutions giving laboratories the flexibility they need to meet the ever-changing COVID-19 testing demand. The best-in-class explorer workstations enable laboratories to efficiently work through the COVID-19 pandemic.”
Related Links:
PerkinElmer, Inc.